Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Drugs - Real World OutcomesOpen Access

Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study

View Full Paper
Ask AI
Bookmark
Share

Authors

RFRong FuHLHui LiuPSPo‐Lan Su

Discussion

Loading...

Member takes

Overview

Real-world data highlights treatment patterns and thrombotic risk in patients with PNH.

Key Points

  • High-LDH patients showed greater perceived disease severity and higher risk of thrombotic events.
  • Approximately 39.3% of patients experienced haemolytic crises, indicating significant disease burden.
  • Anticoagulants were most prescribed, specifically rivaroxaban, for managing complications in PNH patients.
  • Real-world data suggests current management focuses on symptom relief rather than addressing underlying causes.

Cite This Study

Fu et al. (2025) studied this question.

synapsesocial.com/papers/68c24317b210217d647a5561https://doi.org/10.1007/s40801-025-00512-y
View Full Paper
Ask AI
Bookmark
Share